Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan

BACKGROUND: This post-marketing surveillance (PMS) study evaluated the safety and effectiveness of long-term darbepoetin alfa (darbepoetin) for the treatment of renal anemia in Japanese non-dialysis chronic kidney disease patients. METHODS: Patients were treated with darbepoetin and followed up for...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Exp Nephrol
Egile Nagusiak: Tanaka, Tetsuhiro, Nangaku, Masaomi, Imai, Enyu, Tsubakihara, Yoshiharu, Kamai, Masatoshi, Wada, Michihito, Asada, Shinji, Akizawa, Tadao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Singapore 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510805/
https://ncbi.nlm.nih.gov/pubmed/30182223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-018-1632-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak